Ganaxolone
-
Marinus Pharmaceuticals Loses 80 Percent Market Value Over New Drug
Marinus Pharmaceuticals of Radnor saw its stock price plunge by more than 80 percent Monday because of a setback in an experimental seizure drug, writes…
-
2 Linked to Delaware County Make List of Most Admired CEOs for 2022
The president of Cheyney University and the CEO of Radnor-based Marinus Pharmaceuticals made a Philadelphia Business Journal list of the 26 most admired CEOs in…
-
Radnor’s Marinus Pharmaceuticals Aims to Generate $35 Million from Public Stock Offering
Radnor’s Marinus Pharmaceuticals is looking to raise $35 million from its public offering of 9.3 million shares of its common stock priced at $3.75 per…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
